132 related articles for article (PubMed ID: 3098255)
1. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
Demol P; Wingender W; Weihrauch TR; Graefe KH
Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
[TBL] [Abstract][Full Text] [Related]
4. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Müller P; Dammann HG; Simon B
Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
[TBL] [Abstract][Full Text] [Related]
5. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
[TBL] [Abstract][Full Text] [Related]
6. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
Dammann HG; Rehner M; Walter TA; Müller P; Simon B
Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
[TBL] [Abstract][Full Text] [Related]
7. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
[TBL] [Abstract][Full Text] [Related]
8. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers.
Tolman KG; Detweiler MK; Harrison CA; Rollins DE; Simon DA; Brady C; McCormack GH; Bryant EC
J Clin Pharmacol; 1988 Jan; 28(1):76-80. PubMed ID: 3127431
[TBL] [Abstract][Full Text] [Related]
9. Morphological and physiological effects of a cytoprotective prostaglandin analog (rioprostil) on the rat gastric mucosa.
Morris GP; Keenan CM; Shriver DA
Clin Invest Med; 1987 May; 10(3):121-31. PubMed ID: 3113797
[TBL] [Abstract][Full Text] [Related]
10. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
Vantrappen G; Janssens J
Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
[TBL] [Abstract][Full Text] [Related]
11. Rioprostil, a new prostaglandin E1 analogue does not affect glucose homeostasis in healthy volunteers.
Eichler HG; Korn A; Businger JA; Waldhäusl WK
Arch Int Pharmacodyn Ther; 1989; 298():288-92. PubMed ID: 2502955
[TBL] [Abstract][Full Text] [Related]
12. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
Guslandi M; Passaretti S; Tittobello A; Fasani R
Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
[TBL] [Abstract][Full Text] [Related]
13. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
Cohen A; Tolman KG; Lewis GP; Brown S; van Horn A; McCormack GH; Simon DM
Scand J Gastroenterol Suppl; 1989; 164():81-90; discussion 90-1. PubMed ID: 2510286
[TBL] [Abstract][Full Text] [Related]
14. Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin.
Katz LB; Shriver DA
J Pharmacol Exp Ther; 1989 Nov; 251(2):774-81. PubMed ID: 2509683
[TBL] [Abstract][Full Text] [Related]
15. [Protective effect of misoprostol on the changes of transgastric potential difference induced by aspirin in man].
Bergmann JF; Simoneau G; Naudin R; Caulin C; Segrestaa JM
Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):135-8. PubMed ID: 1904163
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
Simon B; Dammann HG; Müller P
Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
[TBL] [Abstract][Full Text] [Related]
17. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
Shriver DA; Katz LB; Rosenthale ME
Scand J Gastroenterol Suppl; 1989; 164():10-20. PubMed ID: 2510252
[TBL] [Abstract][Full Text] [Related]
18. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
Demol P; Wingender W; Kuhlmann J
Scand J Gastroenterol Suppl; 1989; 164():68-71; discussion 71-2. PubMed ID: 2510284
[TBL] [Abstract][Full Text] [Related]
19. The effects of rioprostil on gastric emptying and intragastric acidity.
Penston JG; Johnston DA; Wormsley KG
Hepatogastroenterology; 1986 Jun; 33(3):120-2. PubMed ID: 3091468
[TBL] [Abstract][Full Text] [Related]
20. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
Svendsen LB; Stener Jørgensen F; Hart Hansen O; Johansen A; Horn T; Larsen JK
Digestion; 1987; 37(1):29-34. PubMed ID: 3111919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
